Cyana Therapeutics
PrivateLast Round
Seed
Dec 22, 2025
Total Funding Raised
$150,974
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cyana Therapeutics is a biotechnology company that provides immuno-oncology therapies designed for patients to restore the body's natural anti-cancer immune response.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyana Therapeutics Comparables
Compare Cyana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aerska | 81% | |
| Denali Therapeutics | 71% | |
| Secarna Pharmaceuticals | 71% |
Cyana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 22, 2025 |
Key People
Founding team and executive leadership
Cyana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 51% MoM.
- Dec 22, 2025
$151K round led by Collage Venture Partners
Cyana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cyana Therapeutics's valuation, stock price, and market status.
Is Cyana Therapeutics a public or private company?
Cyana Therapeutics is a private company.
What is the current stock price of Cyana Therapeutics?
Cyana Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cyana Therapeutics worth (valuation)?
Valuation information for Cyana Therapeutics is not publicly available.
Can I buy Cyana Therapeutics stock?
Cyana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cyana Therapeutics's last funding round?
Cyana Therapeutics's most recent funding round was Seed on December 22, 2025.
Who are the main investors in Cyana Therapeutics?
Key investors in Cyana Therapeutics include Collage Venture Partners.
Will Cyana Therapeutics IPO soon?
No public IPO plans have been announced for Cyana Therapeutics.
How can I track Cyana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cyana Therapeutics's secondary market activity and sign up for updates.